COPD Advisor Channel

MeiLan K. Han, MD, and Paul Enright, MD, share their opposing perspectives on the necessity and utility of defining “pre-COPD” in at-risk patients.

This review of current literature discusses emerging therapies directed at COPD endotypes and pathobiological processes that manifest as the disease.

Chronic obstructive pulmonary disease (COPD) continues to be a major cause of disability and is one of the leading causes of mortality worldwide. Here, we summarize COPD pathology, available treatment options and additional potential pathways and targets for new therapeutic development.